Following Actavis’ acquisition of Allergan, anticipated in 2Q15, Brent Saunders will continue to lead the global company as chief executive officer and president and a member of the board of directors. Paul Bisaro will remain executive chairman of the board. Mr. Saunders will lead an expanded senior management team comprised of leaders from both Actavis and Allergan.  “We are committed to realizing the full potential of the historic combination of Actavis and Allergan beginning on Day 1,...